{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:03:38Z","timestamp":1791918218875,"version":"4.3.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA07611"],"award-info":[{"award-number":["AA07611"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA07462"],"award-info":[{"award-number":["AA07462"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA10721"],"award-info":[{"award-number":["AA10721"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA20908"],"award-info":[{"award-number":["AA20908"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["AA019366"],"award-info":[{"award-number":["AA019366"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00213-019-5174-y","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T08:49:16Z","timestamp":1550047756000},"page":"1887-1900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats"],"prefix":"10.1007","volume":"236","author":[{"given":"Robert A.","family":"Waeiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheketha R.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-1920","authenticated-orcid":false,"given":"Zachary A.","family":"Rodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"7","key":"5174_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/add.12941","volume":"110","author":"SA Agboola","year":"2015","unstructured":"Agboola SA, Coleman T, McNeill A, Leonardi-Bee J (2015) Abstinence and relapse among smokers who use varenicline in a quit attempt-a pooled analysis of randomized controlled trials. Addiction 110(7):1182\u20131193","journal-title":"Addiction"},{"key":"5174_CR2","doi-asserted-by":"crossref","unstructured":"Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC (2016) Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: A randomized clinical trial. JAMA 315(4):371\u2013379","DOI":"10.1001\/jama.2015.19284"},{"key":"5174_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJM198811173192005","volume":"319","author":"NL Benowitz","year":"1988","unstructured":"Benowitz NL (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318\u20131330","journal-title":"N Engl J Med"},{"issue":"6","key":"5174_CR4","first-page":"755","volume":"57","author":"G Biala","year":"2005","unstructured":"Biala G, Budzynska B, Kruk M (2005) Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep 57(6):755\u2013760","journal-title":"Pharmacol Rep"},{"key":"5174_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(93)90434-J","volume":"249","author":"O Blomqvist","year":"1993","unstructured":"Blomqvist O, Engel JA, Nissbrandt H, Soderpalm B (1993) The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol 249:207\u2013213","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5174_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/01.ALC.0000153544.83656.3C","volume":"29","author":"GR Breese","year":"2005","unstructured":"Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, L\u00ea DA, O\u2019Dell LE, Overstreet DH, Roberts AJ, Sinha R, Valdez GR, Weiss F (2005) Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29(2):185\u2013195","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.lfs.2010.06.002","volume":"87","author":"AF Ceylan-Isik","year":"2010","unstructured":"Ceylan-Isik AF, McBride SM, Ren J (2010) Sex difference in alcoholism: who is at a greater risk for development of alcoholic complication? Life Sci 87:133\u2013138","journal-title":"Life Sci"},{"key":"5174_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/01.ALC.0000065435.12068.24","volume":"27","author":"H Chi","year":"2003","unstructured":"Chi H, de Wit H (2003) Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res 27:780\u2013786","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"5174_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.drugalcdep.2004.03.001","volume":"75","author":"A Clark","year":"2004","unstructured":"Clark A, Little HJ (2004) Interactions between low concentrations of ethanol and nicotine on firing rate of ventral tegmental dopamine neurones. Drug Alcohol Depend 75(2):199\u2013206","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"5174_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-8993(94)90401-4","volume":"653","author":"WA Corrigall","year":"1994","unstructured":"Corrigall WA, Coen KM, Adamson KL (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653(1\u20132):278\u2013284","journal-title":"Brain Res"},{"issue":"1","key":"5174_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1300\/J069v18n01_04","volume":"18","author":"LS Covey","year":"1999","unstructured":"Covey LS, Glassman AH, Stetner F (1999) Naltrexone effects on short-term and long-term smoking cessation. J Addict Dis 18(1):31\u201340","journal-title":"J Addict Dis"},{"issue":"2","key":"5174_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/acer.13562","volume":"42","author":"CL Czachowski","year":"2018","unstructured":"Czachowski CL, Froehlich JC, DeLory M (2018) The effects of long-term varenicline administration on ethanol and sucrose seeking and self-administration in male P rats. Alcohol Clin Exp Res 42(2):453\u2013460","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"5174_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/alcalc\/35.2.171","volume":"35","author":"JB Daeppen","year":"2000","unstructured":"Daeppen JB, Smith TL, Danko GP, Gordon L, Landi NA, Nurnberger JI, Bucholz KK, Raimo E, Schuckit MA (2000) Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. Alcohol Alcohol 35(2):171\u2013175","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"5174_CR14","doi-asserted-by":"publisher","first-page":"e004393","DOI":"10.1136\/bmjopen-2013-004393","volume":"4","author":"SP David","year":"2014","unstructured":"David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ (2014) Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open 4(3):e004393","journal-title":"BMJ Open"},{"issue":"11","key":"5174_CR15","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/acer.12854","volume":"39","author":"A de Bejczy","year":"2015","unstructured":"de Bejczy A, L\u00f6f E, Walther L, Guterstam J, Hammarberg A, Asanovska G, Franck J, Isaksson A, S\u00f6derpalm B (2015) Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial. Alcohol Clin Exp Res 39(11):2189\u20132199","journal-title":"Alcohol Clin Exp Res"},{"issue":"23","key":"5174_CR16","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1007\/s00213-015-4056-1","volume":"232","author":"GJ Deehan","year":"2015","unstructured":"Deehan GJ, Hauser SR, Waeiss RA, Knight CP, Toalston JE, Truitt WA, McBride WJ, Rodd ZA (2015) Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats. Psychopharmacology 232(23):4293\u20134302","journal-title":"Psychopharmacology"},{"key":"5174_CR17","doi-asserted-by":"crossref","unstructured":"Delnevo CD, Wackowski OA, Giovenco DP, Manderski MT, Hrywna M, Ling PM (2012) Examining market trends in the United States smokeless tobacco use: 2005\u20132011. Tob Control","DOI":"10.1136\/tobaccocontrol-2012-050739"},{"issue":"1","key":"5174_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.alcohol.2011.08.011","volume":"46","author":"R Dhaher","year":"2012","unstructured":"Dhaher R, Toalston JE, Hauser SR, Bell RL, McKinzie DL, McBride WJ, Rodd ZA (2012) Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats. Alcohol 46(1):17\u201327","journal-title":"Alcohol"},{"issue":"2","key":"5174_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.15288\/jsa.1990.51.130","volume":"51","author":"JR DiFranza","year":"1990","unstructured":"DiFranza JR, Guerrera MP (1990) Alcoholism and smoking. J Stud Alcohol 51(2):130\u2013135","journal-title":"J Stud Alcohol"},{"key":"5174_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/ntr\/ntp118","volume":"11","author":"H Digard","year":"2009","unstructured":"Digard H, Errington G, Richter A, McAdams K (2009) Patterns and behaviors of snus consumption in Sweden. Nicotine Tob Res 11:1175\u20131181","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"5174_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ntr\/nts123","volume":"15","author":"H Digard","year":"2013","unstructured":"Digard H, Proctor C, Kulasekaran A, Malmqvist U, Richter A (2013) Determination of nicotine absorption from multiple tobacco products and nicotine gum. Nicotine Tob Res 15(1):255\u2013261","journal-title":"Nicotine Tob Res"},{"issue":"6","key":"5174_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/add.12875","volume":"110","author":"K Donoghue","year":"2015","unstructured":"Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C (2015) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Addiction 110(6):920\u2013930","journal-title":"Addiction"},{"issue":"11","key":"5174_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1177\/1060028014545806","volume":"48","author":"BL Erwin","year":"2014","unstructured":"Erwin BL, Slaton RM (2014) Varenicline in the treatment of alcohol use disorders. Ann Pharmacother 48(11):1445\u20131455","journal-title":"Ann Pharmacother"},{"issue":"18","key":"5174_CR24","doi-asserted-by":"publisher","first-page":"7577","DOI":"10.1073\/pnas.1103000108","volume":"108","author":"R Exley","year":"2011","unstructured":"Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S, Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux JP, Maskos U, Cragg SJ, Faure P (2011) Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine. Proc Natl Acad Sci U S A 108(18):7577\u20137582","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"5174_CR25","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/acer.13157","volume":"40","author":"JC Froehlich","year":"2016","unstructured":"Froehlich JC, Fischer SM, Dilley JE, Nicholson ER, Smith TN, Filosa NJ, Rademacher LC (2016) Combining varenicline (Chantix) with naltrexone decreases alcohol drinking more effectively than does either drug alone in a rodent model of alcoholism. Alcohol Clin Exp Res 40(9):1961\u20131970","journal-title":"Alcohol Clin Exp Res"},{"issue":"8","key":"5174_CR26","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/acer.13432","volume":"41","author":"JC Froehlich","year":"2017","unstructured":"Froehlich JC, Nicholson ER, Dilley JE, Filosa NJ, Rademacher LC, Smith TN (2017) Varenicline reduces alcohol intake during repeated cycles of alcohol reaccess following deprivation in alcohol-preferring (P) rats. Alcohol Clin Exp Res 41(8):1510\u20131517","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbr.2015.09.009","volume":"296","author":"D Funk","year":"2016","unstructured":"Funk D, Lo S, Coen K, L\u00ea AD (2016) Effects of varenicline on operant self-administration of alcohol and\/or nicotine in a rat model of co-abuse. Behav Brain Res 296:157\u2013162","journal-title":"Behav Brain Res"},{"issue":"4","key":"5174_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00213-010-2024-3","volume":"213","author":"O George","year":"2011","unstructured":"George O, Lloyd A, Carroll FI, Damaj MI, Koob GF (2011) Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology 213(4):715\u2013722","journal-title":"Psychopharmacology"},{"key":"5174_CR29","doi-asserted-by":"crossref","unstructured":"Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 296(1):47\u201355","DOI":"10.1001\/jama.296.1.47"},{"issue":"7","key":"5174_CR30","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.neuropharm.2010.01.013","volume":"58","author":"SR Grady","year":"2010","unstructured":"Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ (2010) Structural differences determine the relative selectivity of nicotinic compounds for native \u03b14\u03b22*-, \u03b16\u03b22*-, \u03b13\u03b24*- and \u03b17-nicotinic acetylcholine receptors. Neuropharmacology 58(7):1054\u20131066","journal-title":"Neuropharmacology"},{"issue":"11","key":"5174_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","volume":"61","author":"B Grant","year":"2004","unstructured":"Grant B, Hasin D, Chou S, Stinson F, Dawson D (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61(11):1107\u20131115","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"5174_CR32","first-page":"172","volume":"29","author":"R Grucza","year":"2006","unstructured":"Grucza R, Bierut L (2006) Co-occurring risk factors for alcohol dependence and habitual smoking: update on findings from the Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health 29(3):172\u2013178","journal-title":"Alcohol Res Health"},{"issue":"2\u20133","key":"5174_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.drugalcdep.2009.10.017","volume":"107","author":"R Gueorguieva","year":"2010","unstructured":"Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O\u2019Malley SS (2010) Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study. Drug Alcohol Depend 107(2\u20133):221\u2013229","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5174_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15288\/jsa.1995.56.202","volume":"56","author":"S Gulliver","year":"1995","unstructured":"Gulliver S, Rohsenow DJ, Colby SM, Dey AN, Abrams DB, Niaura RS, Monti PM (1995) Interrelationship of smoking and alcohol dependence, use and urges to use. J Stud Alcohol 56(2):202\u2013206","journal-title":"J Stud Alcohol"},{"key":"5174_CR35","unstructured":"Gurley DA, Lanthorn TH (1998) Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes. Neurosci Lett 247(2\u20133):107\u2013110"},{"issue":"1","key":"5174_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1530-0277.2011.01579.x","volume":"36","author":"SR Hauser","year":"2012","unstructured":"Hauser SR, Getachew B, Oster SM, Dhaher R, Ding ZM, Bell RL, McBride WJ, Rodd ZA (2012a) Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner. Alcohol Clin Exp Res 36(1):43\u201354","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR37","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/j.1530-0277.2012.01800.x","volume":"36","author":"SR Hauser","year":"2012","unstructured":"Hauser SR, Katner SN, Deehan GA Jr, Ding ZM, Toalston JE, Scott BJ, Bell RL, McBride WJ, Rodd ZA (2012b) Development of an oral operant nicotine\/ethanol co-use model in alcohol-preferring (P) rats. Alcohol Clin Exp Res 36:1963\u20131972","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"5174_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/adb.12048","volume":"19","author":"SR Hauser","year":"2014","unstructured":"Hauser SR, Bracken AL, Deehan GA, Toalston JE, Ding ZM, Truitt WA, Bell RL, McBride WJ, Rodd ZA (2014) Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine. Addict Biol 19(5):800\u2013811","journal-title":"Addict Biol"},{"issue":"2","key":"5174_CR39","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1530-0277.1993.tb00778.x","volume":"17","author":"CW Hodge","year":"1993","unstructured":"Hodge CW, Haraguchi M, Erickson H, Samson HH (1993) Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding. Alcohol Clin Exp Res 17(2):370\u2013375","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fnbeh.2017.00029","volume":"11","author":"JY Holgate","year":"2017","unstructured":"Holgate JY, Shariff M, Mu EH, Bartlett S (2017) A rat drinking in the dark model for studying ethanol and sucrose consumption. Front Behav Neurosci 11:29","journal-title":"Front Behav Neurosci"},{"key":"5174_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2017.11.017","volume":"184","author":"RT Hurt","year":"2018","unstructured":"Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, Hays JT (2018) Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: a randomized controlled trial. Drug Alcohol Depend 184:12\u201317","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5174_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0376-8716(02)00315-0","volume":"69","author":"U John","year":"2003","unstructured":"John U, Hill A, Rumpf H, Hapke U, Meyer C (2003a) Alcohol high risk drinking, abuse and dependence among tobacco smoking medical care patients and the general population. Drug Alcohol Depend 69(2):189\u2013195","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"5174_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/alcalc\/agg082","volume":"38","author":"U John","year":"2003","unstructured":"John U, Rumpf H, Hanke M, Gerke P, Hapke U (2003b) Estimation of tobacco- or alcohol-attributable disease rates in national hospital care: an approach based on routine in-patient disease register data and systematic diagnosis of alcohol use disorders. Alcohol Alcohol 38(4):339\u2013346","journal-title":"Alcohol Alcohol"},{"issue":"18","key":"5174_CR44","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","volume":"311","author":"DE Jonas","year":"2014","unstructured":"Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC (2014) Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. Jama 311(18):1889\u20131900","journal-title":"Jama"},{"issue":"1","key":"5174_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","volume":"296","author":"DE Jorenby","year":"2006","unstructured":"Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296(1):56\u201363","journal-title":"JAMA"},{"key":"5174_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pbb.2016.05.010","volume":"148L","author":"CR Kasten","year":"2016","unstructured":"Kasten CR, Frazee AM, Boehm SL 2nd (2016) Developing a model of limited-access nicotine consumption in C57Bl\/6J mice. Pharmacol Biochem Behav 148L:28\u201337","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"5174_CR47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/JCP.0b013e3182676956","volume":"32","author":"A King","year":"2012","unstructured":"King A, Cao D, O\u2019Malley S, Kranzler H, Cai X, deWit H, Matthews A, Stachoviak R (2012) Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol 32(5):630\u2013636","journal-title":"J Clin Psychopharmacol"},{"key":"5174_CR48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s11064-010-0181-8","volume":"35","author":"A Lajtha","year":"2010","unstructured":"Lajtha A, Sershen H (2010) Nicotine: alcohol reward interactions. Neurochem Res 35:1248\u20131258","journal-title":"Neurochem Res"},{"issue":"20","key":"5174_CR49","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00213-014-3541-2","volume":"231","author":"AD L\u00ea","year":"2014","unstructured":"L\u00ea AD, Funk D, Lo S, Coen K (2014) Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse. Psychopharmacology 231(20):4019\u20134029","journal-title":"Psychopharmacology"},{"key":"5174_CR50","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1124\/jpet.111.185306","volume":"339","author":"SC Lummis","year":"2011","unstructured":"Lummis SC, Thompson AJ, Bencherif M, Lester HA (2011) Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. J Phamacol Exp Ther 339:125\u2013131","journal-title":"J Phamacol Exp Ther"},{"issue":"5","key":"5174_CR51","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00213-018-4853-4","volume":"235","author":"SE Maggio","year":"2018","unstructured":"Maggio SE, Saunders MA, Baxter TA, Nixon K, Prendergast MA, Zheng G, Crooks P, Dwoskin LP, Slack RD, Newman AH, Bell RL, Bardo MT (2018a) Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. Psychopharmacology 235(5):1439\u20131453","journal-title":"Psychopharmacology"},{"key":"5174_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugalcdep.2018.09.008","volume":"193","author":"SE Maggio","year":"2018","unstructured":"Maggio SE, Saunders MA, Nixon K, Prendergast MA, Zheng G, Crooks P, Dwoskin LP, Bell RL, Bardo MT (2018b) An improved model of ethanol and nicotine co-use in female P rats: effects of naltrexone, varenicline, and the selective nicotinic \u03b16\u03b22* antagonist r-bPiDI. Drug Alcohol Depend 193:154\u2013161","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"5174_CR53","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","volume":"108","author":"NC Maisel","year":"2013","unstructured":"Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108(2):275\u2013293","journal-title":"Addiction"},{"issue":"2\u20133","key":"5174_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF02244930","volume":"112","author":"DH Malin","year":"1993","unstructured":"Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112(2\u20133):339\u2013342","journal-title":"Psychopharmacology"},{"issue":"1","key":"5174_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0091-3057(95)00202-2","volume":"53","author":"DH Malin","year":"1996","unstructured":"Malin DH, Lake JR, Payne MC, Short PE, Carter VA, Cunningham JS, Wilson OB (1996) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible. Pharmacol Biochem Behav 53(1):81\u201385","journal-title":"Pharmacol Biochem Behav"},{"key":"5174_CR56","unstructured":"Martell N (2014) Tobacco returns to the bar, this time inside cocktails. National Public Radio. Retrieved from \n                    https:\/\/www.npr.org\/"},{"key":"5174_CR57","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1530-0277.1998.tb03718.x","volume":"22","author":"DL McKinzie","year":"1998","unstructured":"McKinzie DL, Nowak KL, Yorger L, McBride WJ, Murphy JM, Lumeng L, Li T-K (1998) The alcohol deprivation effect in the alcohol-preferring P rat under free drinking and operant access conditions. Alcohol Clin Exp Res 22:1170\u20131176","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1530-0277.2002.tb02540.x","volume":"26","author":"RI Melendez","year":"2002","unstructured":"Melendez RI, Rodd-Henricks ZA, Engleman EA, Li TK, McBride WJ, Murphy JM (2002) Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol. Alcohol Clin Exp Res 26:318\u2013325","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.alcohol.2003.12.002","volume":"32","author":"RI Melendez","year":"2004","unstructured":"Melendez RI, Rodd ZA, McBride WJ, Murphy JM (2004) Involvement of the mesopallidal dopamine system in ethanol reinforcement. Alcohol 32:137\u2013144","journal-title":"Alcohol"},{"key":"5174_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drugalcdep.2016.10.018","volume":"169","author":"CA Motschman","year":"2016","unstructured":"Motschman CA, Gass JC, Wray JM, Germeroth LJ, Schlienz NJ, Munoz DA, Moore FE, Rhodes JD, Hawk LW, Tiffany ST (2016) Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: a systematic review on varenicline. Drug Alcohol Depend 169:180\u2013189","journal-title":"Drug Alcohol Depend"},{"key":"5174_CR61","volume-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, DC","edition":"8"},{"key":"5174_CR62","unstructured":"New York Times Magazine (Marshall Selladec) (2003) The 3rd Annual Year in Ideas; Nicotini, The. Published Dec 14, 2003"},{"issue":"3","key":"5174_CR63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00213-009-1739-5","volume":"208","author":"EC O\u2019Connor","year":"2010","unstructured":"O\u2019Connor EC, Parker D, Rollema H, Mead AN (2010) The \u03b14\u03b22 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology 208(3):365\u2013376","journal-title":"Psychopharmacology"},{"issue":"2","key":"5174_CR64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1176\/ajp.153.2.281","volume":"153","author":"SS O\u2019Malley","year":"1996","unstructured":"O\u2019Malley SS, Jaffe AJ, Rode S, Rounsaville BJ (1996) Experience of a \u201cslip\u201d among alcoholics treated with naltrexone or placebo. Am J Psychiatry 153(2):281\u2013283","journal-title":"Am J Psychiatry"},{"issue":"6","key":"5174_CR65","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/archinte.166.6.667","volume":"166","author":"SS O\u2019Malley","year":"2006","unstructured":"O\u2019Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P (2006) A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med 166(6):667\u2013674","journal-title":"Arch Intern Med"},{"issue":"6","key":"5174_CR66","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/ntr\/ntr284","volume":"14","author":"NC Ortiz","year":"2012","unstructured":"Ortiz NC, O\u2019Neill HC, Marks MJ, Grady SR (2012) Varenicline blocks \u03b22*-nAChR-mediated response and activates \u03b24*-nAChR-mediated responses in mice in vivo. Nicotine Tob Res 14(6):711\u2013719","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"5174_CR67","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/npp.2011.283","volume":"37","author":"I Petrakis","year":"2012","unstructured":"Petrakis I, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal J (2012) Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology 37(4):996\u20131004","journal-title":"Neuropsychopharmacology"},{"issue":"14","key":"5174_CR68","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00213-015-3878-1","volume":"232","author":"PA Randall","year":"2015","unstructured":"Randall PA, Jaramillo AA, Frisbee S, Besheer J (2015) The role of varenicline on alcohol-primed self-administration and seeking behavior in rats. Psychopharmacology 232(14):2443\u20132454","journal-title":"Psychopharmacology"},{"key":"5174_CR69","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/sj.npp.1300214","volume":"28","author":"ZA Rodd","year":"2003","unstructured":"Rodd ZA, Bell RL, Kuc KA, Murphy JM, Lumeng L, Li TK, McBride WJ (2003) Effects of repeated alcohol deprivations on operant ethanol self-administration by alcohol-preferring (P) rats. Neuropsychopharmacology 28:1614\u20131621","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"5174_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1124\/jpet.105.084350","volume":"315","author":"ZA Rodd","year":"2005","unstructured":"Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ (2005) Prolonged increase in the sensitivity of the posterior ventral tegmental area to the reinforcing effects of ethanol following repeated exposure to cycles of ethanol access and deprivation. J Pharmacol Exp Ther 315(2):648\u2013657","journal-title":"J Pharmacol Exp Ther"},{"key":"5174_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1369-1600.2008.00140.x","volume":"14","author":"ZA Rodd","year":"2009","unstructured":"Rodd ZA, Bell RL, Kuc KA, Murphy JM, Lumeng L, McBride WJ (2009) Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of high-alcohol-drinking (HAD) rats. Addict Biol 14:152\u2013164","journal-title":"Addict Biol"},{"issue":"3","key":"5174_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.alcohol.2010.01.002","volume":"44","author":"ZA Rodd","year":"2010","unstructured":"Rodd ZA, Bell RL, Oster SM, Toalston JE, Pommer TJ, McBride WJ, Murphy JM (2010) Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats. Alcohol 44(3):245\u2013255","journal-title":"Alcohol"},{"key":"5174_CR73","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s002139900347","volume":"149","author":"ZA Rodd-Henricks","year":"2000","unstructured":"Rodd-Henricks ZA, McKinzie DL, Crile RS, Murphy JM, McBride WJ (2000) Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. Psychopharmacology 149:217\u2013224","journal-title":"Psychopharmacology"},{"key":"5174_CR74","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/j.1530-0277.2001.tb02328.x","volume":"25","author":"ZA Rodd-Henricks","year":"2001","unstructured":"Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK (2001) Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring rats. Alcohol Clin Exp Res 25:1140\u20131150","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR75","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/j.1530-0277.2002.tb02465.x","volume":"26","author":"ZA Rodd-Henricks","year":"2002","unstructured":"Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK (2002a) Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure. Alcohol Clin Exp Res 26:1632\u20131641","journal-title":"Alcohol Clin Exp Res"},{"key":"5174_CR76","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/j.1530-0277.2002.tb02466.x","volume":"26","author":"ZA Rodd-Henricks","year":"2002","unstructured":"Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK (2002b) Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure. Alcohol Clin Exp Res 26:1642\u20131652","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"5174_CR77","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","volume":"52","author":"H Rollema","year":"2007","unstructured":"Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FI, Williams KE (2007) Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52(3):985\u2013994","journal-title":"Neuropharmacology"},{"key":"5174_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/IJAMH.2006.18.1.139","volume":"18","author":"HJ Sable","year":"2006","unstructured":"Sable HJ, Bell RL, Rodd ZA, McBride WJ (2006) Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats. Int J Adolesc Med Health 18:139\u2013149","journal-title":"Int J Adolesc Med Health"},{"key":"5174_CR79","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2015.09.002","volume":"156","author":"G Scuppa","year":"2015","unstructured":"Scuppa G, Cippitelli A, Toll L, Ciccocioppo R, Ubaldi M (2015) Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. Drug Alcohol Depend 156:126\u2013132","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5174_CR80","first-page":"273","volume":"19","author":"PH Smith","year":"2017","unstructured":"Smith PH, Weinberger AH, Zhang J, Emme E, Mazure CM, McKee SA (2017) Sex differences in smoking cessation pharmacotherapy comparative efficacy: a network meta-analysis. Nicotine Tob Res 19(3):273\u2013281","journal-title":"Nicotine Tob Res"},{"key":"5174_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0166-4328(00)00203-5","volume":"113","author":"B Soderpalm","year":"2000","unstructured":"Soderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113:85\u201396","journal-title":"Behav Brain Res"},{"issue":"12","key":"5174_CR82","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/14656566.2017.1349098","volume":"18","author":"M Soyka","year":"2017","unstructured":"Soyka M, M\u00fcller CA (2017) Pharmacotherapy of alcoholism - an update on approved and off-label medications. Expert Opin Pharmacother 18(12):1187\u20131199","journal-title":"Expert Opin Pharmacother"},{"key":"5174_CR83","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","volume":"18","author":"R Spanagel","year":"1997","unstructured":"Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54\u201359","journal-title":"Trends Pharmacol Sci"},{"issue":"1\u20133","key":"5174_CR84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0014-2999(96)00174-4","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, H\u00f6lter SM, Allingham K, Landgraf R, Zieglg\u00e4nsberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305(1\u20133):39\u201344","journal-title":"Eur J Pharmacol"},{"issue":"30","key":"5174_CR85","doi-asserted-by":"publisher","first-page":"12518","DOI":"10.1073\/pnas.0705368104","volume":"104","author":"P Steensland","year":"2007","unstructured":"Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE (2007) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104(30):12518\u201312523","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5174_CR86","first-page":"1","volume":"12","author":"A Thompson","year":"2017","unstructured":"Thompson A, Ashcroft DM, Owens L, van Staa TP, Pirmohamed M (2017) Drug therapy for alcohol dependence in primary care in the UK: a Clinical Practice Research Datalink study. PLoS One 12(3):1\u201314","journal-title":"PLoS One"},{"issue":"3","key":"5174_CR87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1530-0277.2002.tb02551.x","volume":"26","author":"Y Tizabi","year":"2002","unstructured":"Tizabi Y, Copeland RJ, Louis VA, Taylor RE (2002) Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res 26(3):394\u2013399","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"5174_CR88","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/alcalc\/agm057","volume":"42","author":"Y Tizabi","year":"2007","unstructured":"Tizabi Y, Bai L, Copeland RJ, Taylor RE (2007) Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell. Alcohol Alcohol 42(5):413\u2013416","journal-title":"Alcohol Alcohol"},{"key":"5174_CR89","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.alcohol.2008.01.011","volume":"42","author":"JE Toalston","year":"2008","unstructured":"Toalston JE, Oster SM, Kuc KA, Pommer TJ, Murphy JM, Lumeng L, Bell RL, McBride WJ, Rodd ZA (2008) Effects of alcohol and saccharin deprivations on concurrent ethanol and saccharin operant self-administration by alcohol-preferring (P) rats. Alcohol 42:277\u2013284","journal-title":"Alcohol"},{"issue":"3","key":"5174_CR90","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2010.04.015","volume":"2010","author":"B Toll","year":"2010","unstructured":"Toll B, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O\u2019Malley S (2010) Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend 2010(3):200\u2013206","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5174_CR91","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00213-014-3702-3","volume":"232","author":"WA Truitt","year":"2015","unstructured":"Truitt WA, Hauser SR, Deehan GJ, Toalston JE, Wilden JA, Bell RL, McBride WJ, Rodd ZA (2015) Ethanol and nicotine interaction within the posterior ventral tegmental area in male and female alcohol-preferring rats: evidence of synergy and differential gene activation in the nucleus accumbens shell. Psychopharmacology 232(3):639\u2013649","journal-title":"Psychopharmacology"},{"issue":"11","key":"5174_CR92","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O\u2019Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49(11):876\u2013880","journal-title":"Arch Gen Psychiatry"},{"key":"5174_CR93","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archpsyc.1997.01830200071010","volume":"54","author":"JR Volpicelli","year":"1997","unstructured":"Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O\u2019Brien CP (1997) Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry 54:737\u2013742","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"5174_CR94","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1037\/0022-006X.67.4.555","volume":"67","author":"DW Wetter","year":"1999","unstructured":"Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB (1999) Gender differences in smoking cessation. J Consult Clin Psychol 67(4):555\u2013562","journal-title":"J Consult Clin Psychol"},{"issue":"8","key":"5174_CR95","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1046\/j.1360-0443.1999.948122713.x","volume":"94","author":"G Wong","year":"1999","unstructured":"Wong G, Wolter T, Croghan G, Croghan I, Offord K, Hurt R (1999) A randomized trial of naltrexone for smoking cessation. Addiction 94(8):1227\u20131237","journal-title":"Addiction"},{"issue":"2","key":"5174_CR96","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/tobaccocontrol-2011-050371","volume":"21","author":"S Zhu","year":"2012","unstructured":"Zhu S, Lee M, Zhuang Y, Gamst A, Wolfson T (2012) Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades? Tob Control 21(2):110\u2013118","journal-title":"Tob Control"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-5174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-5174-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-5174-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:17:20Z","timestamp":1589620640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-5174-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5174"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-5174-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"23 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}